Unknown

Dataset Information

0

GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun.


ABSTRACT: With the widespread use of rifampicin and isoniazid, bacterial resistance has become a growing problem. Additionally, the lack of relevant baseline information for the frequency of drug-resistant tuberculosis (TB) gene mutations is a critical issue, and the incidence of this infection in the city of Changchun has not investigated to date. However, compared with the slow traditional methods of drug susceptibility testing, recently developed detection methods, such as rifampicin and isoniazid resistance-related gene chip techniques, allow for rapid, easy detection and simultaneous testing for mutation frequency and drug resistance.In this study, the rifampicin and isoniazid resistance-related gene mutation chip method was employed for an epidemiological investigation. To assess the gene mutation characteristics of drug-resistant TB and evaluate the chip method, we tested 2143 clinical specimens from patients from the infectious diseases hospital of Changchun city from January to December 2016. The drug sensitivity test method was used as the reference standard.The following mutation frequencies of sites in the rifampicin resistance gene rpoB were found: Ser531Leu (52.6%), His526Tyr (12.3%), and Leu511Pro (8.8%). The multidrug-resistance (MDR)-TB mutation frequency was 34.7% for rpoB Ser531Leu and katG Ser315Thr, 26.4% for rpoB Ser531Leu and inhA promoter -?15 (C???T), and 10.7% for rpoB His526Tyr and katG Ser315Thr. In addition, drug susceptibility testing served as a reference standard. In previously treated clinical cases, the sensitivity and specificity of GeneChip were 83.1 and 98.7% for rifampicin resistance, 79.9 and 99.6% for isoniazid resistance, and 74.1 and 99.8% for MDR-TB.Our experimental results show that the chip method is accurate and reliable; it can be used to detect the type of drug-resistant gene mutation in clinical specimens. Moreover, this study can be used as a reference for future research on TB resistance baselines.

SUBMITTER: Zhang MJ 

PROVIDER: S-EPMC5964880 | biostudies-other | 2018 May

REPOSITORIES: biostudies-other

altmetric image

Publications

GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun.

Zhang Ming-Jin MJ   Ren Wen-Zhi WZ   Sun Xue-Juan XJ   Liu Yang Y   Liu Ke-Wei KW   Ji Zhong-Hao ZH   Gao Wei W   Yuan Bao B  

BMC infectious diseases 20180522 1


<h4>Background</h4>With the widespread use of rifampicin and isoniazid, bacterial resistance has become a growing problem. Additionally, the lack of relevant baseline information for the frequency of drug-resistant tuberculosis (TB) gene mutations is a critical issue, and the incidence of this infection in the city of Changchun has not investigated to date. However, compared with the slow traditional methods of drug susceptibility testing, recently developed detection methods, such as rifampicin  ...[more]

Similar Datasets

| S-EPMC6817024 | biostudies-literature
| S-EPMC8008859 | biostudies-literature
| S-EPMC10787229 | biostudies-literature
| S-EPMC7200664 | biostudies-literature
| S-EPMC10224971 | biostudies-literature
| S-EPMC4349813 | biostudies-literature
| S-EPMC3577857 | biostudies-literature
| S-EPMC10575498 | biostudies-literature
| S-EPMC7012596 | biostudies-literature
2012-09-18 | GSE40917 | GEO